Investigator Initiated Studies
The Investigator-Initiated Study (IIS) Grant program at Collegium supports original research conducted by non-Collegium physicians and researchers in predetermined therapeutic areas.
The goal of each IIS is to further research related to Collegium’s current and future therapeutic areas of interest.
Therapeutic areas of interest include:
Treatment of chronic pain in:
- Patients requiring feeding tubes
- Geriatric patients
- Patients with dysphagia
- Palliative care/Hospice patients
- Patients with cancer
The Impact of Abuse-deterrent Technology on:
- Misuse and Abuse
- Interruption and impact of various trajectories to addiction
- Prevention of overdose
Studies that help assess and quantify measures of household risk
If you or a colleague would like additional information, please contact Collegium at: ResearchGrantReviewCommittee@collegiumpharma.com